{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:45:08Z","timestamp":1792701908504,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:00:00Z","timestamp":1567209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:00:00Z","timestamp":1567209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["under grant agreement IP12.87"],"award-info":[{"award-number":["under grant agreement IP12.87"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["under grant agreement 282521, the SAFEGUARD project"],"award-info":[{"award-number":["under grant agreement 282521, the SAFEGUARD project"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Magn Reson Mater Phy"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10334-019-00773-z","type":"journal-article","created":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T09:39:50Z","timestamp":1567417190000},"page":"73-80","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Renal sinus fat and renal hemodynamics: a cross-sectional analysis"],"prefix":"10.1007","volume":"33","author":[{"given":"Karlinde A.","family":"Spit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel H. A.","family":"Muskiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Tonneijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H. H.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap A.","family":"Joles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneloes","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2894-6124","authenticated-orcid":false,"given":"Daniel H.","family":"van Raalte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,31]]},"reference":[{"key":"773_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","volume":"126","author":"JP Despr\u00e9s","year":"2012","unstructured":"Despr\u00e9s JP (2012) Body fat distribution and risk of cardiovascular disease: an update. Circulation 126:1301\u20131313","journal-title":"Circulation"},{"key":"773_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1053\/j.ajkd.2008.03.003","volume":"52","author":"MC Foster","year":"2008","unstructured":"Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS et al (2008) Overweight, obesity, and the development of stage 3 CKD: the framingham heart study. Am J Kidney Dis 52:39\u201348","journal-title":"Am J Kidney Dis"},{"key":"773_CR3","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1038\/sj.ijo.0802858","volume":"28","author":"JP Montani","year":"2004","unstructured":"Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG (2004) Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes 28:S58","journal-title":"Int J Obes"},{"key":"773_CR4","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1093\/eurheartj\/ehn387","volume":"29","author":"GR Hajer","year":"2008","unstructured":"Hajer GR, Van Haeften TW, Visseren FLJ (2008) Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 29:2959\u20132971","journal-title":"Eur Heart J"},{"key":"773_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrneph.2016.145","volume":"12","author":"F Artunc","year":"2016","unstructured":"Artunc F, Schleicher E, Weigert C, Fritsche A, Stefan N, H\u00e4ring HU (2016) The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol 12:721","journal-title":"Nat Rev Nephrol"},{"key":"773_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","volume":"2","author":"APJ De Vries","year":"2014","unstructured":"De Vries APJ, Ruggenenti P, Ruan XZ, Praga M, Cruzado JM, Bajema IM et al (2014) Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol 2:417\u2013426","journal-title":"Lancet Diabetes Endocrinol"},{"key":"773_CR7","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1161\/HYPERTENSIONAHA.111.175315","volume":"58","author":"MC Foster","year":"2011","unstructured":"Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, Fox CS (2011) Fatty kidney, hypertension, and chronic kidney disease: the framingham heart study. Hypertension 58:784\u2013790","journal-title":"Hypertension"},{"key":"773_CR8","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/ndt\/gfq522","volume":"26","author":"O Lamacchia","year":"2011","unstructured":"Lamacchia O, Nicastro V, Camarchio D, Valente U, Grisorio R, Gesualdo L et al (2011) Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients. Nephrol Dial Transplant 26:892\u2013898","journal-title":"Nephrol Dial Transplant"},{"key":"773_CR9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1161\/HYPERTENSIONAHA.110.157370","volume":"56","author":"HL Chughtai","year":"2010","unstructured":"Chughtai HL, Morgan TM, Rocco M, Stacey B, Brinkley TE, Ding J et al (2010) Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension 56:901\u2013906","journal-title":"Hypertension"},{"key":"773_CR10","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1007\/s00125-012-2551-z","volume":"55","author":"R Wagner","year":"2012","unstructured":"Wagner R, MaChann J, Lehmann R, Rittig K, Schick F, Lenhart J et al (2012) Exercise-induced albuminuria is associated with perivascular renal sinus fat in individuals at increased risk of type 2 diabetes. Diabetologia 55:2054\u20132058","journal-title":"Diabetologia"},{"key":"773_CR11","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1161\/HYPERTENSIONAHA.110.158535","volume":"56","author":"AHA Mazairac","year":"2010","unstructured":"Mazairac AHA, Joles JA (2010) Renal sinus adiposity and hypertension. Hypertension 56:814","journal-title":"Hypertension"},{"key":"773_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11154-016-9346-3","volume":"17","author":"DI Siegel-Axel","year":"2016","unstructured":"Siegel-Axel DI, H\u00e4ring HU (2016) Perivascular adipose tissue: an unique fat compartment relevant for the cardiometabolic syndrome. Rev Endocr Metab Disord 17:51\u201360","journal-title":"Rev Endocr Metab Disord"},{"key":"773_CR13","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1161\/ATVBAHA.114.303035","volume":"34","author":"S Lim","year":"2014","unstructured":"Lim S, Meigs JB (2014) Links between ectopic fat and vascular disease in humans. Arterioscler Thromb Vasc Biol 34:1820\u20131826","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"773_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.vph.2012.02.003","volume":"56","author":"EC Eringa","year":"2012","unstructured":"Eringa EC, Bakker W, van Hinsbergh VWM (2012) Paracrine regulation of vascular tone, inflammation and insulin sensitivity by perivascular adipose tissue. Vasc Pharmacol 56:204\u2013209","journal-title":"Vasc Pharmacol"},{"key":"773_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.vph.2018.02.004","volume":"106","author":"CBA Restini","year":"2018","unstructured":"Restini CBA, Ismail A, Kumar RK, Burnett R, Garver H, Fink GD et al (2018) Renal perivascular adipose tissue: form and function. Vasc Pharmacol 106:37\u201345","journal-title":"Vasc Pharmacol"},{"key":"773_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11892-011-0186-y","volume":"11","author":"RI Meijer","year":"2011","unstructured":"Meijer RI, Serne EH, Smulders YM, Van Hinsbergh VWM, Yudkin JS, Eringa EC (2011) Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease. Curr Diabetes Rep 11:211\u2013217","journal-title":"Curr Diabetes Rep"},{"key":"773_CR17","doi-asserted-by":"publisher","first-page":"e009579","DOI":"10.1136\/bmjopen-2015-009579","volume":"5","author":"MM Smits","year":"2015","unstructured":"Smits MM, Tonneijck L, Muskiet MHA, Hoekstra T, Kramer MHH, Pieters IC et al (2015) Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes. BMJ Open 5:e009579","journal-title":"BMJ Open"},{"issue":"7","key":"773_CR18","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s00125-016-3938-z","volume":"59","author":"L Tonneijck","year":"2016","unstructured":"Tonneijck L, Smits MM, Muskiet MHA, Hoekstra T, Kramer MHH, Danser AHJ et al (2016) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial. Diabetologia 59(7):1412\u20131421","journal-title":"Diabetologia"},{"key":"773_CR19","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.2337\/dc16-1371","volume":"39","author":"L Tonneijck","year":"2016","unstructured":"Tonneijck L, Smits MM, Muskiet MHA, Hoekstra T, Kramer MHH, Danser AHJ et al (2016) Renal effects of DPP-4 inhibitor sitagliptin or GLP-1 receptor agonist liraglutide in overweight patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial. Diabetes Care 39:2042\u20132050","journal-title":"Diabetes Care"},{"key":"773_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2369-12-52","volume":"12","author":"MC Foster","year":"2011","unstructured":"Foster MC, Hwang S, Porter SA, Massaro JM, Hoffmann U, Fox CS (2011) Development and reproducibility of a computed tomography-based measurement of renal sinus fat. BMC Nephrol 12:52","journal-title":"BMC Nephrol"},{"key":"773_CR21","doi-asserted-by":"publisher","first-page":"302","DOI":"10.5603\/FM.2014.0016","volume":"73","author":"V Caglar","year":"2014","unstructured":"Caglar V, Songur A, Acar M, Uygur R, Alkoc OA, Acar T (2014) Volumetric evaluation of fat in the renal sinus in normal subjects using stereological method on computed tomography images and its relationship with body composition. Folia Morphol 73:302\u2013308","journal-title":"Folia Morphol"},{"key":"773_CR22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ebiom.2016.10.020","volume":"13","author":"G Krievina","year":"2016","unstructured":"Krievina G, Tretjakovs P, Skuja I, Silina V, Keisa L, Krievina D et al (2016) Ectopic adipose tissue storage in the left and the right renal sinus is asymmetric and associated with serum kidney injury molecule-1 and fibroblast growth factor-21 levels increase. EBioMedicine 13:274\u2013283","journal-title":"EBioMedicine"},{"key":"773_CR23","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1093\/ndt\/gfh470","volume":"19","author":"P G\u00e6de","year":"2004","unstructured":"G\u00e6de P, Tarnow L, Vedel P, Parving HH, Pedersen O (2004) Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. Nephrol Dial Transplant 19:2784\u20132788","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"773_CR24","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1681\/ASN.2016060666","volume":"28","author":"L Tonneijck","year":"2017","unstructured":"Tonneijck L, Muskiet MHA, Smits MM, van Bommel EJ, Heerspink HJL, van Raalte DH et al (2017) Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J Am Soc Nephrol 28(4):1023\u20131039. \nhttps:\/\/doi.org\/10.1681\/ASN.2016060666","journal-title":"J Am Soc Nephrol"},{"key":"773_CR25","doi-asserted-by":"publisher","first-page":"49S","DOI":"10.1016\/S0895-7061(97)00075-7","volume":"10","author":"J Hall","year":"2003","unstructured":"Hall J (2003) Mechanisms of abnormal renal sodium handling in obesity hypertension*1. Am J Hypertens 10:49S\u201355S","journal-title":"Am J Hypertens"},{"key":"773_CR26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1161\/HYPERTENSIONAHA.112.196717","volume":"60","author":"Y Doi","year":"2012","unstructured":"Doi Y, Iwashima Y, Yoshihara F, Kamide K, Hayashi SI, Kubota Y et al (2012) Renal resistive index and cardiovascular and renal outcomes in essential hypertension. Hypertension 60:770\u2013777","journal-title":"Hypertension"},{"key":"773_CR27","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.clnu.2017.04.007","volume":"37","author":"H Zelicha","year":"2018","unstructured":"Zelicha H, Schwarzfuchs D, Shelef I, Gepner Y, Tsaban G, Tene L et al (2018) Changes of renal sinus fat and renal parenchymal fat during an 18-month randomized weight loss trial. Clin Nutr 37:1145\u20131153","journal-title":"Clin Nutr"}],"container-title":["Magnetic Resonance Materials in Physics, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10334-019-00773-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10334-019-00773-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10334-019-00773-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T23:23:02Z","timestamp":1598743382000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10334-019-00773-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,31]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["773"],"URL":"https:\/\/doi.org\/10.1007\/s10334-019-00773-z","relation":{},"ISSN":["0968-5243","1352-8661"],"issn-type":[{"value":"0968-5243","type":"print"},{"value":"1352-8661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,31]]},"assertion":[{"value":"15 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None with respect to the current manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the medical ethics committee of the VU University Medical Center (Amsterdam, The Netherlands), registered at ClinicalTrials.gov (NCT01744236) and was conducted in accordance with the Declaration of Helsinki and the International Conference on Harmonization of Good Clinical Practice.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participants prior to performing any study-specific activity.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}